David Wilson

David Ian Wilson is the founder of WG Partners LLP, established in 2011, where the title held is Chairman.
Current jobs include Independent Non-Executive Director at Bionomics Ltd. since 2016, Director at CS Pharmaceuticals Ltd. since 2021, Non Executive Director at Chuangsheng Qiao Kang Pharmaceutical Co., Ltd., Non-Executive Director at Neuphoria Therapeutics, Inc. since 2024, Senior Board Advisor at Sapia Partners LLP, and Member-Governors Board at Harris Academy Bromley since 2015.
Former jobs include Chief Executive Officer at Piper Sandler Ltd., Deputy Chief Executive Officer at Matrix Corporate Capital LLP in 2011, Independent Non-Executive Director at Optos Plc from 2012 to 2013, Non-Executive Director at Oncoinvent ASA from 2013 to 2016, Head-Small Companies Corporate Finance at Deutsche Bank AG from 1998 to 1999, Joint Head-UK Investment Banking Group at ING Barings Group LLC from 1999 to 2001, and Head-Small Companies Corporate Broking at UBS AG (London Branch).
Education includes undergraduate degree from the University of Cambridge.